Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Carbonell C, Marcos M, Guillén-Del-Castillo A, Rubio-Rivas M, Argibay A, Marín-Ballvé A, Rodríguez-Pintó I, Baldà-Masmiquel M, Callejas-Moraga E, Colunga D, Sáez-Comet L, González-Echávarri C, Ortego-Centeno N, Marí-Alfonso B, Vargas-Hitos JA, Todolí-Parra JA, Trapiella L, Herranz-Marín MT, Freire M, Castro-Salomó A, Perales-Fraile I, Madroñero-Vuelta AB, Sánchez-García ME, Ruiz-Muñoz M, González-García A, Sánchez-Redondo J, de-la-Red-Bellvis G, Fernández-Luque A, Muela-Molinero A, Lledó GM, Tolosa-Vilella C, Fonollosa-Pla V, Chamorro AJ, Simeón-Aznar CP; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS). Carbonell C, et al. Autoimmun Rev. 2022 Oct;21(10):103167. doi: 10.1016/j.autrev.2022.103167. Epub 2022 Aug 2. Autoimmun Rev. 2022. PMID: 35931315 Free article. Review.
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement.
Iniesta Arandia N, Espinosa G, Tolosa Vilella C, Guillén Del Castillo A, Rubio Rivas M, Freire M, Vargas Hitos JA, Todolí Parra JA, Rodríguez Carballeira M, Marín Ballvé A, Colunga Argüelles D, González de Echávarri Pérez de Heredia C, Ortego-Centeno N, Trapiella Martínez L, Pla Salas X, Chamorro AJ, Perales Fraile I, Ruiz Muñoz M, Fernández de la Puebla Giménez RÁ, Madroñero Vuelta AB, Pons Martín Del Campo I, Jiménez Pérez de Heredia I, González García A, Fonollosa Pla V, Simeón Aznar CP; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS). Iniesta Arandia N, et al. Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):106-114. Epub 2020 Jan 14. Clin Exp Rheumatol. 2020. PMID: 31969223 Free article.
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.
Prevete I, Espinosa G, Bellisai F, Bortoluzzi A, Conti F, Fredi M, Fonseca-Aizpuru EM, García de Viedma V, González-García A, González-León R, Iaccarino L, Iannone F, Marín-Ballvé A, Mitjavila F, Pallarés L, Piga M, Ríos-Garcés R, Suárez S, Tani C, Zanetti A, Ruiz-Irastorza G, Sebastiani GD; Gruppo di Studio SIR sul Lupus Eritematoso Sistemico di recente insorgenza-Early Lupus and Registro Español de pacientes con Lupus Eritematoso Sistémico (RELES), Autoimmune Diseases Study Group (GEAS). Prevete I, et al. Clin Exp Rheumatol. 2020 Sep-Oct;38(5):925-932. Epub 2020 Jan 20. Clin Exp Rheumatol. 2020. PMID: 31969225 Free article.
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González-Echávarri C, Ortego-Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP; RESCLE investigators, Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Autoimmun Rev. 2020 May;19(5):102507. doi: 10.1016/j.autrev.2020.102507. Epub 2020 Mar 17. Autoimmun Rev. 2020. PMID: 32194200
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain.
Rodilla E, López-Carmona MD, Cortes X, Cobos-Palacios L, Canales S, Sáez MC, Campos Escudero S, Rubio-Rivas M, Díez Manglano J, Freire Castro SJ, Vázquez Piqueras N, Mateo Sanchis E, Pesqueira Fontan PM, Magallanes Gamboa JO, González García A, Madrid Romero V, Tamargo Chamorro L, González Moraleja J, Villanueva Martínez J, González Noya A, Suárez-Lombraña A, Gracia Gutiérrez A, López Reboiro ML, Ramos Rincón JM, Gómez Huelgas R; SEMI-COVID-19 Network. Rodilla E, et al. Hypertension. 2021 Mar 3;77(3):856-867. doi: 10.1161/HYPERTENSIONAHA.120.16563. Epub 2020 Dec 30. Hypertension. 2021. PMID: 33377393 Free PMC article.
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].
Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González-Echávarri C, Ortego-Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP; RESCLE investigators; Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Autoimmun Rev. 2021 May;20(5):102793. doi: 10.1016/j.autrev.2021.102793. Epub 2021 Mar 22. Autoimmun Rev. 2021. PMID: 33766615 No abstract available.
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID.
Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, Ramos-Martínez A, Muñez-Rubio E, Fernández Carracedo E, Tejada Montes J, Rubio-Rivas M, Arnalich-Fernandez F, Beato Pérez JL, García Bruñén JM, Del Corral Beamonte E, Pesqueira Fontan PM, Carmona MDM, Fernández-Madera Martínez R, González García A, Salazar Mosteiro C, Tuñón de Almeida C, González Moraleja J, Deodati F, Martín Escalante MD, Asensio Tomás ML, Gómez Huelgas R, Casas Rojo JM, Millán Núñez-Cortés J; SEMI-COVID-19 Network. Calderón-Parra J, et al. PLoS One. 2021 May 11;16(5):e0251340. doi: 10.1371/journal.pone.0251340. eCollection 2021. PLoS One. 2021. PMID: 33974637 Free PMC article.
In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain.
Suárez-García I, Perales-Fraile I, González-García A, Muñoz-Blanco A, Manzano L, Fabregate M, Díez-Manglano J, Aizpuru EF, Fernández FA, García AG, Gómez-Huelgas R, Ramos-Rincón JM; SEMI-COVID-19 Network. Suárez-García I, et al. PLoS One. 2021 Aug 3;16(8):e0255524. doi: 10.1371/journal.pone.0255524. eCollection 2021. PLoS One. 2021. PMID: 34343222 Free PMC article.
275 results